as 01-17-2025 4:00pm EST
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Founded: | N/A | Country: | United States |
Employees: | N/A | City: | ALACHUA |
Market Cap: | 813.6M | IPO Year: | N/A |
Target Price: | $15.00 | AVG Volume (30 days): | 614.5K |
Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.33 | EPS Growth: | N/A |
52 Week Low/High: | $5.55 - $18.96 | Next Earning Date: | 03-04-2025 |
Revenue: | $180,855,000 | Revenue Growth: | 18.79% |
Revenue Growth (this year): | 18.91% | Revenue Growth (next year): | 13.02% |
AXGN Breaking Stock News: Dive into AXGN Ticker-Specific Updates for Smart Investing
Zacks
6 days ago
Zacks
6 days ago
GlobeNewswire
8 days ago
GlobeNewswire
9 days ago
Zacks
a month ago
Zacks
a month ago
Simply Wall St.
a month ago
Zacks
2 months ago
The information presented on this page, "AXGN Axogen Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.